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Background: Brugada syndrome (BrS) requires implantation of cardio-
verter-defibrillator (ICD) to prevent sudden cardiac death. However, the ICD
indications in asymptomatic patients are remain conflicting.
Method and Results: We compared the rate of ICD complications in
asymptomatic versus symptomatic BrS patients. ICD interrogations were done
every 3-6 months. Given the low prevalence of BrS in the general population,
10% of the risk α for the bilateral statistical test significance was chosen. We
studied 51 patients, 86.5% male; mean age 47±11 years at diagnosis. At diag-
nosis, 18 patients (35%) were asymptomatic, 25 patients (49%) experienced
syncope, and 8 patients (16%) had been resuscitated from ventricular fibrilla-
tion. During a mean follow-up of 78±46 months, none of asymptomatic patients
experienced appropriate therapy, whereas 21.6% of symptomatic patients had
≥1 shocks. Overall complication rate was 27.4%. Inappropriate shocks (IS)
occurred in 7 patients (13.7%; mean 6.57±6.94 shocks per patient), 16.14±10.38
months after ICD implantation, and lead fracture was the first cause (n=4,
57.1%). The incidence of IS was higher in the asymptomatic patients (p=0.09).
Device-related complications were similar in both groups (p=1). A total of 14
patients (27.4%) had ≥1 complications. The mean interval from implantation to
a complication was 13.91±12.98 months. The most frequent complication was
lead failure in 9 (17.6%). The risk of IS and device-complications at 3 years was
13.7% and 21.6% respectively, and eventually remains constant over the time.
Conclusion: This study demonstrated that ICD has a high risk of compli-
cations, mainly during the early period after the device implantation. A higher
rate of IS as well as a very low risk of arrhythmic events in asymptomatic BrS
patients advocate to carefully evaluate this young and otherwise “healthy”
population for the decision-making.
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Purpose: Atrioventricular (AV) conduction disturbance leading to pace-
maker (PM) implantation is frequent after transcatheter aortic valve implanta-
tion (TAVI). The aim of this study was to assess the incidence and the
predictors of PM implantation after TAVI.
Methods: Between 2010 and 2014, 198 consecutive patients underwent
TAVI in our center. 42 patients were excluded from the study because of a
pre-existing PM before TAVI. 156 patients (62 Corevalve (CV), 94 Edwards
Sapiens valve (ES) were included and prospectively followed during 1 year.
Results: Complete AV block occurred after TAVI in 29 patients (19%),
second degree AV block in 3 (0.05%), new left bundle branch block (LBBB)
in 53 (34%). A PM was implanted in 40 patients (26%). CV patients were
more frequently implanted than ES (35% vs 19%; p=0.03). Post-procedure
PR, QRS duration were longer in the PM group (227 vs 196ms; 159 vs 129ms,
respectively, p<0.001). LBBB was also more frequent (79% vs 53%; p=0.01).
At hospital discharge, 83% of the PM group was stimulated. At 1 month, 10%
were PM dependent and 4% at 6 months. At 1 month, 29% were stimulated
less than 5% of the time and 25% at 6 months. Multivariate analysis showed
that the predictors of PM implantation were a pre-existing RBBB (OR 4.7, IC
1.43-15.52, p=0.01), a pre-existing LBBB (OR 7.28, IC 2.34-22.6, p<0.001),
a per-TAVI complete AV block (OR 4.21, IC 1.52-11.63, p=0.006), a high
prosthesis/annulus diameter ratio (OR 1.1, IC 1.04-1.18, p=0.003) and post-
procedure PR and QRS long duration (OR 1.03, IC 1.01-1.06, p=0.009; OR
1.04, IC 1.01-1.07, p=0.009 respectively). PM implantation had no impact on
survival after TAVI (Logrank=0.92). The increase in LVEF post-TAVI was
lower in PM group: 0.2 vs 8%, p=0.05 at 6 months and -5 vs 9.6%, p=0.004
at 1 year. The NYHA class was similar in both groups at follow up.
Conclusion: TAVI is associated in a great proportion of patients with AV
disturbances which are mostly regressive over time. Patients with pre-existing
RBBB, LBBB and high prosthesis/annulus diameter ratio are at increased risk
of complete AV block. LVEF increase was lower in PM group even with a
low percentage of stimulation time.
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Background: The rate of pacemaker (PM) implantations is continuously
growing. A large number of elderly patients is expected to be implanted in the
future. We aimed at analyzing the short and long-term outcome after PM
replacement in nonagenarians.
Methods: Patients aged ≥90 yo referred for PM replacement from January
2004 to July 2014 were retrospectively included. The primary clinical end-
point was total mortality.
Results: 62 patients were included (93.3±2.9yo at the time of PM replace-
ment). During the follow-up, 37 patients (59.7%) died. Survival rates were
84.2% (95%CI:71.8-91.5%), 66.9% (95%CI:51.8-78.2%) and 22.7%
(95%CI:10.6-37.7%) after 1, 2 and 5 years, respectively. Atrial fibrillation
(OR 2.44, 95%CI:1.07-5.58) and non-physiological pacing, (OR 2.52,
95%CI:1.12-5.65) were independent predictors of mortality.
Conclusion: PM replacement in nonagenarians is a safe and straightfor-
ward procedure. Patients living for a median time of 30 months after the
replacement.
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